RT @DrCycloPath: Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Ir…
RT @DrCycloPath: Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Ir…
RT @DrCycloPath: Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Ir…
RT @DrCycloPath: Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Ir…
RT @DrCycloPath: Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Ir…
RT @DrCycloPath: Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Ir…
RT @DrCycloPath: Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Ir…
RT @DrCycloPath: Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Ir…
Follicular Variant of PTC must have ≥ 2 of 3 (max score) nuclear features: Enlargement, crowding/overlapping Elongation Irregular contours Grooves Pseudoinclusions #EndoPath #PathTwitter #PathResidents WHO's NIFTP and PTC nomenclature reference article ↘️
RT @MKoujyo: 3)の名称の変更ですが、甲状腺がんでは、 2016年にNikiforov YEらがJAMA Oncol.に、境界悪性病変(NIFTP)の用語を使用することを提唱。 https://t.co/r4RlyU56G6 この用語は、17年改訂の内分泌腫瘍のWH…
RT @MKoujyo: 3)の名称の変更ですが、甲状腺がんでは、 2016年にNikiforov YEらがJAMA Oncol.に、境界悪性病変(NIFTP)の用語を使用することを提唱。 https://t.co/r4RlyU56G6 この用語は、17年改訂の内分泌腫瘍のWH…
3)の名称の変更ですが、甲状腺がんでは、 2016年にNikiforov YEらがJAMA Oncol.に、境界悪性病変(NIFTP)の用語を使用することを提唱。 https://t.co/r4RlyU56G6 この用語は、17年改訂の内分泌腫瘍のWHO分類第4版に境界病変 (FT-UMP、WDT-UMP、NIFTP) として採用されました。
RT @Aiims1742: @PearlF Changes in nomenclature can have significant impact on overtreatment. A great example is NIFTP of the thyroid. htt…
@PearlF Changes in nomenclature can have significant impact on overtreatment. A great example is NIFTP of the thyroid. https://t.co/Pne1rX8saz
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
NIFTP、適切なフォロー間隔がよくわからんのよね
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @yuka_pathology: NIFTPを聞いたとき言葉遊びみたいで何なんだって感じたけど、こんなに重要な疾患概念だったなんて!とても勉強になります。
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @yuka_pathology: NIFTPを聞いたとき言葉遊びみたいで何なんだって感じたけど、こんなに重要な疾患概念だったなんて!とても勉強になります。
NIFTPを聞いたとき言葉遊びみたいで何なんだって感じたけど、こんなに重要な疾患概念だったなんて!とても勉強になります。
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
RT @minaniyasashiku: 後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIF…
後者を悪性のカテゴリーからはずし乳頭癌様核を有する非浸潤性甲状腺濾胞性腫瘍(noninvasive follicular thyroid neoplasm with papillary-like nuclear features:NIFTP)の用語を使用することが提唱されました.これまで癌 と診断されてきた腫瘍の一群を癌とよばないことで(6/n)https://t.co/ODONxFsy0e
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @Aiims1742: @EricTopol @DrLauraEsserman @bmj_latest The analogous example in thyroid is the renaming of “encapsulated follicular variant…
En el campo de los tumores de tiroides, un tipo común de cáncer de tiroides recientemente se ha bajado de categoría al quitar la palabra cáncer (carcinoma) de su nombre. https://t.co/HlaAdYCgQa
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
I use the diagnosis much less often than I thought I would #CytoChat
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
RT @CancerCytopath: Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced usi…
Let's jump in. Nikiforov et al (2016) defined histologic criteria for diagnosing NIFTP. What hurdles have you faced using the new NIFTP category in your surgical pathology practice? https://t.co/QwVjoAfCXo #CytoChat
If a patient read about the NIFTP reclassification in JAMA, would Dr. Livolsi then think them eligible to have their pathology reviewed? 🤔 https://t.co/L1PRsGC5pB
@EricTopol @DrLauraEsserman @bmj_latest The analogous example in thyroid is the renaming of “encapsulated follicular variants of papillary thyroid carcinoma” (indolent, non-metastatic lesions) as “NIFTP”. The psychological impact of not having “carcinoma”
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @DrAngelicaSilva: Please in the reports incorporate these criteria #thyroid 🇨🇱👩🏻⚕️ https://t.co/KeZOwWjdBc
RT @DrAngelicaSilva: Please in the reports incorporate these criteria #thyroid 🇨🇱👩🏻⚕️ https://t.co/KeZOwWjdBc
RT @DrAngelicaSilva: Please in the reports incorporate these criteria #thyroid 🇨🇱👩🏻⚕️ https://t.co/KeZOwWjdBc
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
@Joaquin_Gom @CirEnd_AEC @maidoayala @BolloEli
RT @TheAAES: When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neop…
When cancer is no longer cancer – Encapsulated Follicular Variant of Papillary Cancer now Non-invasive Follicular Thyroid Neoplasm w/ Papillary-like nuclear features (NIFTP). https://t.co/2GB90JS6KC #CheckYourThyroid #THYCAM2018 https://t.co/mPpyGwHdF0 @T
RT @BenMazer: @PathDocBoston @JL_Sauter @EdCibas Please help me understand this since I notice you're an author on the paper. Pseudoinclusi…
@PathDocBoston @JL_Sauter @EdCibas Please help me understand this since I notice you're an author on the paper. Pseudoinclusions seem to be part of the nuclear scoring system for NIFTP? https://t.co/pwhEq8mHzV https://t.co/WFfBOQCv1F
RT @chioseasi: Digital slides of #NIFTP are here: https://t.co/OHmqtMfCxC? #PathJC 8/23 9PM EST https://t.co/k8Rfm6QMjq https://t.co/Slb48L…
RT @SarehParangiMD: Pathology revolution in thyroid cancer! Read it. Means our surgical consults just got looooooonnnnnger https://t.co/EFL…
RT @PrashantBavi: Thyroid cancer nomenclature revised to avoid over-treatment of indolent lesions; EFVPTC = NIFTP. Nifty! #pathology http…
RT @nao73714: 論文はこれだよ。 Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma A Paradigm Shift to Reduce…
論文はこれだよ。 Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma A Paradigm Shift to Reduce Overtreatment of Indolent Tumors https://t.co/hTyDVERrCF
Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/RZlBzuqkvc
・鈴木眞一教授(甲状腺腫瘍診療ガイドライン作成委員会委員) 「抑制的にしているにもかかわらずアメリカ・韓国の過剰診断論から同様に問題とする方がいる」 https://t.co/sfD9tMtPsB ※菊池誠氏/@kikumacoや早野龍五氏などによるあべこべの勘違いにご注意。 https://t.co/IYZZU6xcsy
RT @hayano: Reclassification of a Variant of Thyroid Carcinoma https://t.co/LmwFN5crZN (甲状腺乳頭癌の過剰治療を避けるために)
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE
RT @JAMANetworkOpen: Open Access from the JAMA Network: Reclassification of a Variant of Thyroid Carcinoma https://t.co/jlc8h42pQE